PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2230619

Philosophical integrity and policy development in bioethics.

M Benjamin
View original source ↗Export metadata ↓

Abstract

Critically examining what most people take for granted is central to philosophical inquiry. Philosophers who accept positions on policy making commissions, tasks forces, or committees cannot, however, play the same uncompromisingly critical role in this capacity as they do in the classroom or in their personal research or writing. Still, philosophers have much to contribute to such bodies, and they can do so without compromising their integrity or betraying themselves as philosophers.

Explore related subjects

Advisory CommitteesBioethical IssuesCultural DiversityEthical AnalysisEthicistsEthics, MedicalFetal Tissue TransplantationHealth PolicyHuman ExperimentationHumansInterdisciplinary CommunicationMoral ObligationsMoralsOrgan TransplantationPhilosophy, MedicalSocial JusticeSocial ValuesTissue and Organ ProcurementUncertaintyUnited StatesVirtuesAnalytical ApproachBioethics and Professional EthicsPhilosophical ApproachWarnock CommitteeJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Benjamin. 1990. Philosophical integrity and policy development in bioethics.. https://doi.org/10.1093/jmp%2F15.4.375

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗